News Conference News HFSA 2021 PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF Todd Neale September 13, 2021
News Daily News From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide L.A. McKeown September 06, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2020 Shelley Wood December 31, 2020
News Opinion Editor's Corner Envision Change: A Different Future for Cardiology, Medicine, Research, and Health Shelley Wood December 29, 2020
News Conference News HFSA 2019 DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF L.A. McKeown September 16, 2019
News Conference News CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin Michael O'Riordan March 16, 2018
News Daily News How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues Leah Lawrence August 01, 2017